Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.

European journal of neurology - 1 May 2010

Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R, Pisani F, Rossi A, Calabresi P, Tambasco N

Abstract excerpt

BACKGROUND: Patients with Parkinson's disease (PD) and chronically treated with L-DOPA exhibit, in a percentage of 10-30%, supra-physiological levels of plasma total homocysteinemia (tHcy). In this study, we have investigated, in a group of hyper-homocysteinemic PD patients, the time of hyper-tHc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cross-Sectional Studies
Share to Dopamine Agents
Share to Homocysteine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hyperhomocysteinemia

Share to Levodopa

Share to Parkinson Disease

Share to Secondary Prevention

Share to Vitamin B 12

Source

Identifiers

PMID: 20050890
DOI: 10.1111/j.1468-1331.2009.02894.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20050890-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.PMID 20050890Read ↗

Antiepileptic Drugs and MTHFR Polymorphisms Influence Hyper‐Homocysteinemia Recurrence in Epileptic PatientsSemantic proximity Read ↗

Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease.Semantic proximity Read ↗

Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.Semantic proximity Read ↗

Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.Semantic proximity Read ↗

Antiepileptic drugs as independent predictors of plasma total homocysteine levels.Semantic proximity Read ↗

Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia.Semantic proximity Read ↗

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.